Refractory Anemia With Excess Blasts: Clinical Trials

2 trials for Refractory Anemia With Excess Blasts, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Refractory Anemia With Excess Blasts: new trials by email Literature Review of Refractory Anemia With Excess Blasts trials Research Report on Refractory Anemia With Excess Blasts

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay
antitumor drug screening assay, chemotherapy, biological therapy - Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
Not applicableCompletedUniversity of Washington162013-08-022018-07-11
Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes
pravastatin sodium, idarubicin, cytarabine - Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
Not applicableCompletedFred Hutchinson Cancer Center242013-05-012017-11-17

Narrower conditions

Anemia, Refractory, with Excess of Blasts (2)  ·  Congenital Abnormalities (2)  ·  Leukemia, Erythroblastic, Acute (2)  ·  Leukemia, Megakaryoblastic, Acute (2)  ·  Leukemia, Monocytic, Acute (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Leukemia, Myelomonocytic, Acute (2)  ·  Leukemia, Myelomonocytic, Chronic (2)  ·  Myeloproliferative Disorders (2)

Broader conditions

Anemia (2)  ·  Anemia, Refractory (2)  ·  Bone Marrow Diseases (2)  ·  Chronic Disease (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Disease Attributes (2)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Myeloid (2)  ·  Myelodysplastic Syndromes (2)  ·  Myelodysplastic-Myeloproliferative Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Pathologic Processes (2)

Interventions

Biological Therapy (1)  ·  Cytarabine (1)  ·  Drug Screening Assays, Antitumor (1)  ·  Drug Therapy (1)  ·  Idarubicin (1)  ·  Pravastatin (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  University of Washington (1)

Countries

United States (2)

Top investigators

Mazyar Shadman (1)  ·  Pamela Becker (1)

NIH funding

P30CA015704 (2)